Snowball logo
logo
1098

GeneMatrix Inc

109820 • KQ
₩1,450.00₩0.00  (0%)
Estimate
EPS
-104.847
Beta
1.043
Growth
Revenue, YoY
8.07%
Net income, YoY
276.35%
FCF, YoY
55.97%
About the company
Ticker
109820
ISIN
KR7109820001
Country
South Korea
Sector (GICS)
Healthcare
GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment. It also provides biochemical diagnostics, such as special chemistry and general chemistry, that includes semi and full auto analyer, and calibrators and controls. The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Frequently asked questions

What sector does GeneMatrix Inc (109820) operate in?

GeneMatrix Inc belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is GeneMatrix Inc (109820) current stock price?

As of the latest data, GeneMatrix Inc stock price is ₩1,450, with a previous close of ₩1,450.

What is GeneMatrix Inc (109820) current market capitalization?

GeneMatrix Inc market cap is approximately 28.95 billion.

What is GeneMatrix Inc (109820) Earnings Per Share (EPS)?

The trailing EPS is -₩105.

What is GeneMatrix Inc (109820) EBITDA?

GeneMatrix Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 842.11 million.

Does GeneMatrix Inc (109820) pay dividends?

No. GeneMatrix Inc does not pay a dividend.

What is GeneMatrix Inc (109820) beta (volatility) score?

GeneMatrix Inc has a beta of 1.043, meaning its volatility is roughly in line with the market.